Home  >>  News  >>  US Tariffs Shake Up Indian Pharma Industry
US Tariffs Shake Up Indian Pharma Industry

US Tariffs Shake Up Indian Pharma Industry

The US President has introduced tariffs on major imports, including pharmaceuticals, impacting trade dynamics. This move is significant for India, as the Indian pharmaceutical industry supplies nearly half of the generics to the US market. With a revenue of around $50 billion and a growth rate exceeding 9% from 2013 to 2022, India's pharma sector is gearing up to enhance its competitiveness. By focusing on innovation and higher-value products, Indian companies aim to adapt to the new trade landscape and maintain their strong presence in the global market.

Trending News